Peptide2Mol: A Diffusion Model for Generating Small Molecules as Peptide Mimics for Targeted Protein Binding
By: Xinheng He , Yijia Zhang , Haowei Lin and more
Potential Business Impact:
Creates better medicines by copying nature.
Structure-based drug design has seen significant advancements with the integration of artificial intelligence (AI), particularly in the generation of hit and lead compounds. However, most AI-driven approaches neglect the importance of endogenous protein interactions with peptides, which may result in suboptimal molecule designs. In this work, we present Peptide2Mol, an E(3)-equivariant graph neural network diffusion model that generates small molecules by referencing both the original peptide binders and their surrounding protein pocket environments. Trained on large datasets and leveraging sophisticated modeling techniques, Peptide2Mol not only achieves state-of-the-art performance in non-autoregressive generative tasks, but also produces molecules with similarity to the original peptide binder. Additionally, the model allows for molecule optimization and peptidomimetic design through a partial diffusion process. Our results highlight Peptide2Mol as an effective deep generative model for generating and optimizing bioactive small molecules from protein binding pockets.
Similar Papers
Apo2Mol: 3D Molecule Generation via Dynamic Pocket-Aware Diffusion Models
Biomolecules
Designs medicines that fit changing body parts.
A 3D pocket-aware and affinity-guided diffusion model for lead optimization
Machine Learning (CS)
Creates better medicines by improving how they stick.
A 3D pocket-aware and evolutionary conserved interaction guided diffusion model for molecular optimization
Machine Learning (CS)
Finds new medicines by copying nature's best designs.